The health care organizations in the suit claim that HHS' plan to cut hospital reimbursements under Medicare's 340B drug discount program violates the Social Security Act and exceeds the HHS secretary's authority.
CMS says it is has launched a low-volume appeals settlement option for certain health care providers with fewer than 500 pending Medicare Part A or Part B claims appeals as of Nov. 3, as well as an expanded conference facilitation process for certain providers that do not qualify for the low-volume appeals option.
Disneyland officials on Saturday said they had shut down and decontaminated two cooling towers following a 12-person outbreak of Legionnaires' disease, in today's bite-sized hospital and health industry news from California, New York, and Oklahoma.
Several industry stakeholders cited Alex Azar's background, which includes working at Eli Lilly and Company and serving as deputy HHS secretary under the Bush administration, as a valuable asset—but one advocacy group criticized Azar's nomination as advancing "Big Pharma's coup d'etat."
Bill Gates, co-founder of Microsoft and the Bill and Melinda Gates Foundation, announced that he will invest $100 million in a venture capital fund and several start-ups working to fight dementia and Alzheimer's disease.
According to surveys of more than 1,000 health care organizations, engagement is down 1.6 percentage points for managers and directors since 2013. Advisory Board's Sarah Rothenberger details several best practices organizations can follow to boost engagement for these leaders.
The total costs of Kymriah, the first gene therapy for cancer approved in the United States, could surpass $1 million per patient—more than double its $475,000 list price, Liz Szabo writes for Kaiser Health News.